Pancreatitis Clinical Trials

Browse 32 Clinical Trials Across 44 Cities

1 Phase 3 Trial · 92 Clinics

Reviewed by Michael Gill, B. Sc.
10 Clinical Trials Near Me
Top Hospitals for Clinical Trials
Image of University of Pittsburgh Medical Center in Pennsylvania.
University of Pittsburgh Medical Center
Pittsburgh
4Active Trials
8All Time Trials for
2010First Trial
Image of University of Minnesota in Minnesota.
University of Minnesota
Minneapolis
3Active Trials
8All Time Trials for
2010First Trial
Image of Medical University of South Carolina in South Carolina.
Medical University of South Carolina
Charleston
3Active Trials
12All Time Trials for
2011First Trial
Image of Cincinnati Children's Hospital Medical Center in Ohio.
Cincinnati Children's Hospital Medical Center
Cincinnati
2Active Trials
6All Time Trials for
2014First Trial
Image of Indiana University in Indiana.
Indiana University
Indianapolis
2Active Trials
5All Time Trials for
2010First Trial
Top Cities for Clinical Trials
Image of Los Angeles in California.
Los Angeles
8Active Trials
LAC+USC Medical CenterTop Active Site
Image of Indianapolis in Indiana.
Indianapolis
5Active Trials
Indiana UniversityTop Active Site
Most Recent NullTop Treatments for Clinical Trials
Treatment Name
Active Clinical Trials
All Time Trials for
First Recorded Trial
Ketorolac
2
5
2016
Rectal Indomethacin
2
3
2014
Imaging stratification of stages of pancreatitis
1
1
2023
Dose Escalation Level
1
1
2023
Proton pump inhibitor
1
1
2022
Recently Completed Studies with FDA Approved Treatments
Treatment
Year
Sponsor
CREON
2021
AbbVie
Indomethacin
2020
Mayo Clinic

What Are Mission Cure Clinical Trials?

Mission cure clinical trials are ongoing clinical trials to cure pancreatitis. An inflamed pancreas is referred to as pancreatitis. The pancreas is a gland concealed beneath your stomach within the upper belly. The pancreas is in charge of creating hormones that influence how your body handles sugar, along with enzymes that aid in digestion.

The severity of pancreatitis is categorized into two categories: acute and chronic. Acute pancreatitis refers to sudden pancreas inflammation that lasts just a short period, whereas chronic pancreatitis lasts longer and typically causes irreversible damage to the pancreas.

In the mission cure clinical trials, researchers evaluate patient outcomes, medications, and other factors to enhance diagnosis, treatment, symptom management, and the search for a cure for pancreatitis.

Why Is Pancreatitis Being Studied Through Clinical Trials?

Did you know that approximately 220,000 Americans will be diagnosed with acute pancreatitis annually, and around 80,000 will have chronic pancreatitis?

Pancreatitis is a painful condition that results in symptoms like nausea, vomiting, and fever that can significantly interfere with a patient's life and prevent them from leading a happy, healthy lifestyle. Individuals who suffer from chronic pancreatitis are more likely to develop pancreatic cancer.

Chronic pancreatitis causes severe pancreatic degeneration with time and is usually challenging to diagnose. The patients suffer from severe pain since there are not very promising treatment options.

Mission Cure clinical trials could finally enable those afflicted with pancreatitis to be treated and cured of their illness and decrease these chances of developing pancreatic cancer.

What Are The Types Of Treatments Available For Pancreatitis?

Since a cure for pancreatitis has yet to be found, doctors may prescribe the following treatment options to help patients manage the symptoms associated with the condition.

Painkillers

Patients with mild pancreatitis may not require painkillers. However, people with severe pancreatitis may be prescribed painkillers to help alleviate the excruciating stomach ache, a common symptom of this condition.

Nutritional Supplements

If you are diagnosed with severe pancreatitis, you may not be able to eat a proper solid diet for a few days. Therefore, doctors may prescribe nutritional supplements to ensure your body receives all the essential vitamins and nutrients it needs to stay healthy.

Moreover, studies show supplements containing antioxidants like Vitamin C and A can help reduce inflammation associated with pancreatitis.

Antibiotics

Trauma, infection, injuries, or recent surgery are potential causes of pancreatitis. A physician may prescribe antibiotics to allow a patient's body to eliminate the infections. Doctors usually prescribe fluoroquinolones, carbapenem, and metronidazole for treating infections associated with pancreatitis.

What Are Some Recent Breakthrough Clinical Trials For Pancreatitis?

2023: New drug combination for treating pancreatitis - Researchers at Indiana University have recently received permission to study the safety and effectiveness of a new combination of medications for chronic pancreatitis.

Researchers will examine the efficacy of lacosamide, an anti-seizure medication used in conjunction with opioids to treat pancreatitis. The NIH recently provided 1.1 million dollars in financing for the phase 1 clinical trial.

2019: Epidemiology and holistic prevention of pancreatitis - The burden of chronic pancreatitis, acute pancreatitis, and post-pancreatitis diabetes mellitus are discussed in this review using comprehensive and recent data.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 3rd, 2021

Last Reviewed: August 2nd, 2023

References1 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30. https://pubmed.ncbi.nlm.nih.gov/189296862 Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779. Epub 2012 Oct 25. https://pubmed.ncbi.nlm.nih.gov/231002163 Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027. https://pubmed.ncbi.nlm.nih.gov/201895034 Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027. No abstract available. https://pubmed.ncbi.nlm.nih.gov/201895035 Cohen J. A power primer. Psychol Bull. 1992 Jul;112(1):155-9. https://pubmed.ncbi.nlm.nih.gov/195656836 Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1. https://pubmed.ncbi.nlm.nih.gov/280333137 Cohen J. A power primer. Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155. https://pubmed.ncbi.nlm.nih.gov/195656838 Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464. Review. https://pubmed.ncbi.nlm.nih.gov/269776969 Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464. https://pubmed.ncbi.nlm.nih.gov/2697769610 Tenner S, Baillie J, DeWitt J, Vege SS; American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416. doi: 10.1038/ajg.2013.218. Epub 2013 Jul 30. Erratum in: Am J Gastroenterol. 2014 Feb;109(2):302. https://pubmed.ncbi.nlm.nih.gov/23896955